Literature DB >> 16855214

The extracellular release of HMGB1 during apoptotic cell death.

Charles W Bell1, Weiwen Jiang, Charles F Reich, David S Pisetsky.   

Abstract

High mobility group box 1 protein (HMGB1) is a non-histone nuclear protein with dual function. Inside the cell, HMGB1 binds DNA and regulates transcription, whereas outside the cell, it serves as a cytokine and mediates the late effects of LPS. The movement of HMGB1 into the extracellular space has been demonstrated for macrophages stimulated with LPS as well as cells undergoing necrosis but not apoptosis. The differential release of HMGB1 during death processes could reflect the structure of chromatin in these settings as well as the mechanisms for HMGB1 translocation. Since apoptotic cells can release some nuclear molecules such as DNA to which HMGB1 can bind, we therefore investigated whether HMGB1 release can occur during apoptosis as well as necrosis. For this purpose, Jurkat cells were treated with chemical inducers of apoptosis (staurosporine, etoposide, or camptothecin), and HMGB1 release into the medium was assessed by Western blotting. Results of these experiments indicate that HMGB1 appears in the media of apoptotic Jurkat cells in a time-dependent manner and that this release can be reduced by Z-VAD-fmk. Panc-1 and U937 cells treated with these agents showed similar release. In addition, HeLa cells induced to undergo apoptosis showed HMGB1 release. Furthermore, we showed using confocal microscopy that HMGB1 and DNA change their nuclear location in Jurkat cells undergoing apoptosis. Together, these studies indicate that HMGB1 release can occur during the course of apoptosis as well as necrosis and suggest that the release process may vary with cell type.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16855214     DOI: 10.1152/ajpcell.00616.2005

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  204 in total

Review 1.  Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.

Authors:  P Lenert
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

Review 2.  HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease.

Authors:  Helena Erlandsson Harris; Ulf Andersson; David S Pisetsky
Journal:  Nat Rev Rheumatol       Date:  2012-01-31       Impact factor: 20.543

3.  Immunomodulatory drugs regulate HMGB1 release from activated human monocytes.

Authors:  Hanna Schierbeck; Heidi Wähämaa; Ulf Andersson; Helena Erlandsson Harris
Journal:  Mol Med       Date:  2010-04-09       Impact factor: 6.354

4.  High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy.

Authors:  Yoko Oyama; Teruto Hashiguchi; Noboru Taniguchi; Salunya Tancharoen; Tomonori Uchimura; Kamal K Biswas; Ko-Ichi Kawahara; Takao Nitanda; Yoshihisa Umekita; Martin Lotz; Ikuro Maruyama
Journal:  Lab Invest       Date:  2010-03-15       Impact factor: 5.662

Review 5.  HMGB1 and microparticles as mediators of the immune response to cell death.

Authors:  David S Pisetsky; Julie Gauley; Anirudh J Ullal
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

Review 6.  Ménage à Trois in stress: DAMPs, redox and autophagy.

Authors:  Guanqiao Li; Daolin Tang; Michael T Lotze
Journal:  Semin Cancer Biol       Date:  2013-08-28       Impact factor: 15.707

7.  Anti-inflammatory effect of B-type natriuretic peptide postconditioning during myocardial ischemia-reperfusion: involvement of PI3K/Akt signaling pathway.

Authors:  Gangying Hu; Xingyue Huang; Kai Zhang; Hong Jiang; Xiaorong Hu
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

Review 8.  Role of Toll-like receptor-4 in renal graft ischemia-reperfusion injury.

Authors:  Hailin Zhao; Jessica Santiváñez Perez; Kaizhi Lu; Andrew J T George; Daqing Ma
Journal:  Am J Physiol Renal Physiol       Date:  2014-02-12

9.  RAGE-independent autoreactive B cell activation in response to chromatin and HMGB1/DNA immune complexes.

Authors:  Ana M Avalos; Kerstin Kiefer; Jane Tian; Sean Christensen; Mark Shlomchik; Anthony J Coyle; Ann Marshak-Rothstein
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

10.  Capsaicin as an inducer of damage-associated molecular patterns (DAMPs) of immunogenic cell death (ICD) in human bladder cancer cells.

Authors:  Donatella D'Eliseo; Laura Manzi; Francesca Velotti
Journal:  Cell Stress Chaperones       Date:  2013-04-12       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.